Post-polycythemia Vera (Post-PV)
1 clinical trials · Condition
◉ Watch Post-polycythemia Vera (Post-PV)
| Record | Firm | Date |
|---|---|---|
| Efficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis (MF), Post-polycythemia Vera MF, or Post-essential Thrombocythemia MF (NCT02101268) | Sierra Oncology LLC - a GSK company | 2014-06-19 |
Track Post-polycythemia Vera (Post-PV) automatically
Every clearance here is in the API, with alerts when new ones post.